DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Strosberg J, Wolin E, Chasen B. et al.
NETTER-1 Study Group. Health-related quality of life in patients with progressive midgut neuroendocrine tumors treated with 177Lu-Dotatate in the phase III NETTER-1 trial.
J Clin Oncol 2018;
36 (25) 2578-2584
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.